BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33787836)

  • 21. The Current State of Mohs Surgery for the Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
    Siscos SM; Neill BC; Seger EW; Hooton TA; Hocker TLH
    Dermatol Surg; 2020 Oct; 46(10):1267-1271. PubMed ID: 32740213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digit-Sparing Mohs Surgery for Melanoma.
    Terushkin V; Brodland DG; Sharon DJ; Zitelli JA
    Dermatol Surg; 2016 Jan; 42(1):83-93. PubMed ID: 26655701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.
    Stigall LE; Brodland DG; Zitelli JA
    J Am Acad Dermatol; 2016 Nov; 75(5):1015-1021. PubMed ID: 27473456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mohs micrographic surgery versus wide local excision for melanoma in situ: analysis of a nationwide database.
    Phan K; Loya A
    Int J Dermatol; 2019 Jun; 58(6):697-702. PubMed ID: 30604517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence Rate for Melanoma Excised by Mohs Micrographic Surgery Without Immunostaining.
    Vieira C; Jennings T; Renzi MA; Lawrence N; Decker A
    Dermatol Surg; 2022 May; 48(5):492-497. PubMed ID: 35298442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localized sebaceous carcinoma treatment: Wide local excision verses Mohs micrographic surgery.
    Elias ML; Skula SR; Behbahani S; Lambert WC; Schwartz RA
    Dermatol Ther; 2020 Nov; 33(6):e13991. PubMed ID: 32645237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upstaging of melanoma in situ and lentigo maligna treated with Mohs micrographic surgery rarely results in additional surgical management.
    Levoska MA; Schmults CD; Waldman AH
    Arch Dermatol Res; 2020 Dec; 312(10):753-756. PubMed ID: 32002653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanoma of the Face and Mohs Micrographic Surgery: Nationwide Mortality Data Analysis.
    Trofymenko O; Bordeaux JS; Zeitouni NC
    Dermatol Surg; 2018 Apr; 44(4):481-492. PubMed ID: 29561746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mohs micrographic surgery versus wide local excision for head and neck melanoma-
    Phan K; Onggo J; Loya A
    J Dermatolog Treat; 2020 Sep; 31(6):559-562. PubMed ID: 31264932
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
    Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
    J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of primary nonmetastatic melanoma at high-volume academic facilities is associated with improved long-term patient survival.
    Cheraghlou S; Agogo GO; Girardi M
    J Am Acad Dermatol; 2019 Apr; 80(4):979-989. PubMed ID: 30365997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of invasive melanoma of the head and neck treated with Mohs micrographic surgery - A multicenter study.
    Beal BT; Udkoff J; Aizman L; Etzkorn J; Zitelli JA; Miller CJ; Shin TM; Sobanko JF; Brodland DG
    J Am Acad Dermatol; 2023 Sep; 89(3):544-550. PubMed ID: 36642331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mohs micrographic surgery for the treatment of melanoma.
    Hui AM; Jacobson M; Markowitz O; Brooks NA; Siegel DM
    Dermatol Clin; 2012 Jul; 30(3):503-15. PubMed ID: 22800554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mohs micrographic surgery for melanoma: A prospective multicenter study.
    Ellison PM; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2019 Sep; 81(3):767-774. PubMed ID: 31150700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
    Bricca GM; Brodland DG; Ren D; Zitelli JA
    J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of vertical pathology of debulking specimens during Mohs micrographic surgery for lentigo maligna and melanoma in situ.
    Iorizzo LJ; Chocron I; Lumbang W; Stasko T
    Dermatol Surg; 2013 Mar; 39(3 Pt 1):365-71. PubMed ID: 23356872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mohs micrographic surgery versus wide local excision for eyelid melanoma: An analysis of a national database.
    Ramachandran V; Phan K
    J Plast Reconstr Aesthet Surg; 2022 Dec; 75(12):4410-4415. PubMed ID: 36257889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasive Melanoma and Melanoma in Situ Treated With Modified Mohs Micrographic Surgery With En Face Permanent Sectioning: A 10-Year Retrospective Review.
    Heath M; Woody M; Leitenberger J; Latour E; Bar A
    Dermatol Surg; 2020 Aug; 46(8):1004-1013. PubMed ID: 31714384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining for atypical intraepidermal melanocytic proliferation.
    Etzkorn JR; Jew OS; Shin TM; Sobanko JF; Neal DE; Miller CJ
    J Am Acad Dermatol; 2018 Dec; 79(6):1109-1116.e1. PubMed ID: 30003986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique.
    Albertini JG; Elston DM; Libow LF; Smith SB; Farley MF
    Dermatol Surg; 2002 Aug; 28(8):656-65. PubMed ID: 12174054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.